Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major

Archives of Medical Science

Volumn 6, Issue 4, 2010, Pages 584-591

  Tantawy, Azza A G ^a   El Bostany, Eman A ^b   Matter, Randa M ^a   El Ghoroury, Eman A ^b   Ragab, Shadia ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

; thalassaemia; Bone mineral density; Gene polymorphism vitamin D receptor

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; FERRITIN; OSTEOCALCIN; VITAMIN D RECEPTOR;

ARTICLE; BONE DENSITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; EGYPT; FEMALE; FEMUR; FERRITIN BLOOD LEVEL; GENOTYPE; HIP; HUMAN; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREPUBERTY; SCHOOL CHILD; SEX DIFFERENCE; SPINE; THALASSEMIA MAJOR;

EID: 77956802465     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14472     Document Type: Article

References (25)

1. Mahachoklertwattana P, Pootrakul P, Chuansumrit A, et al. Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes. J Bone Miner Metab 2006; 24: 146-52.
2. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adult with beta-thalassaemia major and intermedia. Br J Haematol 2000; 111: 902-7.
3. Lala R, Chiabotto P, Distefano M, Isaia GC, Garofalo F, Piga A. Bone density and metabolism in thalassaemia. J Pediatr Endocrinol Metabolism 1998; 11 Suppl 3: 785-90.
4. Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G, Pagano L. Longitudinal monitoring of bone mineral density in thalassaemic patients. Ggenetic structure and osteoporosis. Acta Pediatrica 1997; 86: 342-6.
5. Naselli M, Vignolo M, Di Battisto E, et al. Long term follow up of skeletal dysplasia in thalassaemia major. J Pediatr Endocrinol Metabolism 1998; 11 Suppl 3: 817-25.
6. Dundar U, Kupesiz A, Ozdem S, et al. Bone metabolism and mineral density in patients with beta-thalassaemia major. Saudi Medical Journal 2007; 28: 1425-9.
7. Wonke B, Jensen C, Hanslip JJ, et al. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metabolism 1998; 11 Suppl 3: 795-801.
8. Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ. Low bone mineral density in adolescents with beta-thalassaemia. Ann NY Acad Sci 2005; 1054: 462-6. (Pubitemid 43031057)
9. Gaudio A, Morabito N, Xourafa A, et al. Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J Endocrinol Invest 2008; 31: 181-4.
10. Carbonell Sala S, Masi L, Marini F, et al. Genetics and pharmacogenetics of osteoporosis. J Endocrinol Invest 2005; 28 (10 Suppl): 2-7.
11. Stewart TL, Ralston SH. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 2000; 166: 235-45.
12. Giguère Y, Rousseau F. The genetics of osteoporosis: "complexities and difficulties". Clin Genet 2000; 57: 161-9.
13. Tokita A, Hisada K, Nishzawa K. Bone disease with vitamin D receptor abnormality. Nippon Rinsho 2002; 60: 385-90.
14. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA. Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 1999; 14: 740-6.
15. Ongphiphadhanakul B. Osteoporosis: the role of genetics and environment. Forum Nutr 2007; 60: 158-67.
16. Ivanova J, Doukova P, Boyanov M, Popivanov P. Fok1 and Bsm1 polymorphisms of VDR gene and bone mineral density in a random Bulgarian population sample. Endocrine 2006; 29: 413-8.
17. Abrams SA, Griffin IJ, Hawthorne KM, et al. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics and bone mineralization rates during puberty. J Bone Miner Res 2005; 20: 945-53.
18. Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and VDR gene polymorphisms? J Bone Miner Res 1998; 13: 363-70.
19. Quesada JM, Casado A, Diaz C, Barrios L, Cuenca-Acevedo R, Dorado G. Allele-frequency determination of Bsm1 and Fok1 polymorphisms of the VDR gene by quantitative real-time PCR (QRT-PCR) in pooled genomic DNA samples. J Steroid Biochem Molecul Biol 2004; 89-90: 209-14. (Pubitemid 38844284)
20. Morabito N, Russo GT, Gaudio A, et al. The "lively" cytokines network in beta-thalassemia major-related osteoporosis. Bone 2007; 40: 1588-94.
21. Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis low bone mass in thalassemia. J Pediatr Endocrinol Metab 2004; 17: 1415-21.
22. Christoforidis A, Kazantzidou E, Tsatra I, et al. Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassemia major. Hormones (Athens) 2007; 6: 334-40.
23. Eren F, Yilmaz N. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major. Int J Clin Pract 2005; 59: 46-51.
24. Angelopoulos NG, Katounda E, Rombopoulos G, et al. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study. J Pediatr Hematol Oncol 2006; 28: 73-8. (Pubitemid 43315662)
25. Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, Kashef S. Bone mineral density in beta-thalassaemia major and intermedia. Indian Pediatr 2007; 44: 29-32.